15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering HealthEquity Inc, 9 rate it Buy or better, 0 sit at Hold, and 1 rate it Sell or worse, a strong buy consensus. Targets span $89.00 to $142.00, a moderate spread. The average target of $113.80 sits 22% above the current $93.37. The rating mix has stayed broadly stable, with Buy-side ratings easing from 11 to 9 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.11 next quarter toward $5.49 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Strong Buy
Strong Buy00%
Buy990%
Hold00%
Sell110%
Strong Sell00%
Based on 10 analysts giving stock ratings to HealthEquity Inc.
As of Sep, 9 of 10 firms rate HQY a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
HQY EPS & revenue forecast
EPS · NEXT QUARTER
$1.11
Range $1.05 – $1.16 · 14 analysts · +16% YoY
Next period, 14 analysts expect HealthEquity Inc to earn $1.11 a share (range $1.05 – $1.16), versus $0.95 a year earlier. Full-year consensus is $4.72, growing to $5.49 the year after.
REVENUE · NEXT QUARTER
$364.0M
Range $359.5M – $366.8M · 14 analysts · +9% YoY
Revenue is expected to reach $364.0M (range $359.5M – $366.8M), +8.8% year-over-year. Full-year consensus is $1.4B, rising to $1.5B next year.
Top analysts covering HealthEquity Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on HQY.
#1
Alexander Paris
Barrington Research · Rank #93
Buy
$110.00+17.8% to target
Overall win rate
54%
+ Follow
#2
Brian Tanquilut
Jefferies · Rank #208
Buy
$108.00+15.7% to target
Overall win rate
42%
+ Follow
#3
C. Gregory Peters
Raymond James · Rank #260
Buy
$100.00+7.1% to target
Overall win rate
45%
+ Follow
#4
Constantine Davides
JMP Securities · Rank #298
Buy
$111.00+18.9% to target
Overall win rate
35%
+ Follow
#5
Scott Schoenhaus
Keybanc · Rank #413
Buy
$125.00+33.9% to target
Overall win rate
30%
+ Follow
HQY stock forecast FAQ
What is HQY's average 12-month price target?+
The 10 analysts with a live target average $113.80 for HealthEquity Inc over the next 12 months, ranging from a $142.00 high to a $89.00 low.
Is HQY stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 10 analyst ratings, 9 are Buy or Strong Buy, 0 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for HQY?+
The Street-high target is $142.00 (Deutsche Bank), and the Street-low is $89.00 (Goldman Sachs). The average of all 10 active targets is $113.80.
How many Wall Street analysts cover HQY?+
10 analysts have an active rating on HealthEquity Inc, and 10 firms carry a live 12-month price target.
Who is the most accurate analyst covering HQY?+
Among analysts who currently cover HQY, Alexander Paris of Barrington Research has the strongest overall Quantellect track record (Rank #93). Their current call is Buy with a $110.00 target.
What is HealthEquity Inc's projected EPS for next quarter?+
The consensus estimate is $1.11 per share (range $1.05 – $1.16) across 14 analysts. Full-year EPS is projected at $4.72, rising to $5.49 the following year.
How much revenue is HealthEquity Inc expected to report next quarter?+
Consensus revenue is $364.0M (range $359.5M – $366.8M). Full-year revenue is projected at $1.4B, growing to $1.5B next year.
Have analysts been upgrading or downgrading HQY lately?+
As of Sep, 9 of 10 firms rate HQY a Buy (0 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their HQY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
